JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Iwamoto, K.
Right arrow Articles by Klaassen, C. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Iwamoto, K.
Right arrow Articles by Klaassen, C. D.

First-pass effect of morphine in rats

K Iwamoto and CD Klaassen

In order to evaluate the first-pass effect of morphine, the pharmacokinetic parameters of 3H-morphine (5 mg/kg) were studied in male Sprague-Dawley rats by comparing the plasma concentrations after oral, intravenous and intraportal administration. Morphine was almost completely absorbed from the gastrointestinal tract, since no significant difference was found in the cumulative urinary excretion of radioactivity after intravenous and oral administration. Route of administration had no affect on plasma half-life (about 115 minutes) of unchanged morphine. In contrast, the area under the plasma concentration vs. time curve for morphine after oral administration was only about 18%, and after intraportal administration about 40% of that observed after intravenous administration. It can be estimated that approximately two-thirds of the overall first-pass effect (82%) of morphine is due to extraction and/or metabolism in the intestine and the remaining one-third by the liver.

Volume 200, Issue 1, pp. 236-244, 01/01/1977
Copyright © 1977 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 Drug Metab. Dispos.Home page
M. K. Shelby, N. J. Cherrington, N. R. Vansell, and C. D. Klaassen
Tissue mRNA Expression of the Rat UDP-Glucuronosyltransferase Gene Family
Drug Metab. Dispos., March 1, 2003; 31(3): 326 - 333.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
J. M. van Ree, M. A. F. M. Gerrits, and L. J. M. J. Vanderschuren
Opioids, Reward and Addiction: An Encounter of Biology, Psychology, and Medicine
Pharmacol. Rev., June 1, 1999; 51(2): 341 - 396.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
K. C. Kwan
Oral Bioavailability and First-Pass Effects
Drug Metab. Dispos., December 1, 1997; 25(12): 1329 - 1336.
[Abstract] [Full Text]

Home page
 J. Pharmacol. Exp. Ther.Home page
K. M. Shanahan, A. M. Evans, and R. L. Nation
Disposition of Morphine in the Rat Isolated Perfused Kidney: Concentration Ranging Studies
J. Pharmacol. Exp. Ther., September 1, 1997; 282(3): 1518 - 1525.
[Abstract] [Full Text]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1977 by the American Society for Pharmacology and Experimental Therapeutics.